Codice QR

Expression of miR-223 to predict outcomes after transcatheter aortic valve implantation

BACKGROUND: Transcatheter aortic valve implantation (TAVI) is an established treatment for aortic stenosis (AS) in patients at increased surgical risk. Up to 29% of patients annually experience major adverse cardiac and cerebrovascular events (MACCE) after TAVI. MicroRNAs (miRNA) are currently widel...

Descrizione completa

Salvato in:
Autori principali: Ceren Eyileten, Alicja Skrobucha, Miłosz Starczyński, Maria Boszko, Joanna Jarosz-Popek, Alex Fitas, Krzysztof J. Filipiak, Janusz Kochman, Zenon Huczek, Bartosz Rymuza, Radosław Wilimski, Mariusz Kuśmierczyk, Jolanta M. Siller-Matula, Marek Postula, Aleksandra Gąsecka
Natura: Artigo
Lingua:Inglês
Pubblicazione: Via Medica 2024-02-01
Serie:Cardiology Journal
Soggetti:
aortic stenosis
transcatheter aortic valve implantation (TAVI)
microRNA
prognosis
Accesso online:https://journals.viamedica.pl/cardiology_journal/article/view/88863
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi